Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial

Wang, XY; Jiang, HF; Zhao, M; Li, J; Gray, F; Sheng, LX; Li, Y; Li, XD; Ling, W; Li, W; Hao, W

Zhao, M (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, 600 South Wan Ping Rd, Shanghai 200030, Peoples R China.; Hao, W (reprint author), Cent S Univ, Natl Clin Res Ctr Mental Disorders, Xiangya Hosp 2, Mental Hlth Inst, 139

ASIA-PACIFIC PSYCHIATRY, 2019; 11 (1):

Abstract

Introduction The purpose of the study is to evaluate the efficacy and safety of buprenorphine/naloxone sublingual tablets for the treatment of opioid ......

Full Text Link